JMP Securities analyst Roy Buchanan reiterated a Buy rating on Arbutus Biopharma (ABUS – Research Report) today and set a price target of $5.00. Don't Miss our Black Friday Offers: Roy Buchanan has ...
Roy Buchanan, an analyst from JMP Securities, reiterated the Buy rating on PolyPid (PYPD – Research Report). The associated price target ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback